Contact Us
  • Choose License Type

U.S. Safety Needles Market, by Product Type ( Fine Aspirating Needle, Biopsy Needle, Hypodermic Needle, Pen Needle, Suture Needle, IV Catheter Needle, Huber Needle, Blood Collection Needle, Spinal Anesthesia and Epidural Needle, Prefilled Syringe Needle, A.V. Fistula Needle, Cannula Needle, and Retractable Syringes), by Application (Sample Collection, Drug Delivery), by End User( Hospitals, Physician Offices, Nursing Home, Dental Laboratories, Diagnostic Centers, Ambulatory Surgical Centers, Homecare Settings, and Others), is estimated to be valued at US$ 2,447.3 million in 2020 and is expected to exhibit a CAGR of 4.8 % over the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.

The increasing technological advancements provide opportunity to the companies to produce products with better quality and less price, with the help of advanced manufacturing processes, companies are producing new products to address the market demand. For instance, in January 2017, a group of researchers in the Center for Nanoscale Bio photonics at the University of Adelaide developed a smart needle with fiber optic camera attached with the computer, enabling neurosurgeons in recognizing blood vessel. The product came into clinical trials in early 2018.

Moreover, key companies focusing on inorganic strategies such as merger and acquisitions to strengthen their positioning in the market. In January 2016, Medtronic Inc, a medical device company acquired Covidien Plc, a medical device company focusing on manufacturing of safety needles and safety syringes, with this acquisition, Medtronic Plc. acquired the Covidien Plc’s portfolio of safety products such as safety needles and services including other product lines of the Covidien Plc

U.S. Safety Needles Market - Impact of Coronavirus (Covid-19) Pandemic.

  • The COVID-19 pandemic has impacted each and every country throughout the world. According to the Coronavirus Disease (COVID-19) Epidemiological Update by the U.S. Department of Health & Human Services, the number of COVID-19 cases reported as of February 3, 2021 in the U.S. are 28.1 million active cases and recorded 4.99 millions of death due to coronavirus
  • Therefore, U.S. governments are taking various initiatives to combat the spread of COVID-19. For instance, in May 2020, the Centers for Disease Control and Prevention started working with the All-of-Government and All-of-America approach to increase testing capacity, improve case detection, and contact tracing across all the U.S. states and re-open the country
  • Moreover, the CDC is working with the state and local partners to define the circumstances where testing of asymptomatic people is likely to be helpful in controlling the pandemic. Furthermore, the CDC is supporting the improvement of current data infrastructure, and the development and integration of digital/technology solutions in various healthcare solutions in order to ensure timely and transparent communication with all citizens including daily new cases, hospitalizations, use of intensive care units (ICU), and mortality by country and/or zip code.
  • Furthermore, key companies are focusing on distributing of safety needles and safety syringes for the hospitals in the U.S. For instance, in January 2021, Becton, Dickson and Company, announced the distribution of 800 million syringes and needles (including safety needles) to the various hospitals conducting COVID-19 vaccination campaigns in the U.S.

Browse 10 Market Data Tables and 31 Figures spread through 176 Pages and in-depth TOC on ‘U.S. Safety Needles Market, by Product Type ( Fine Aspirating Needle, Biopsy Needle, Hypodermic Needle, Pen Needle, Suture Needle, IV Catheter Needle, Huber Needle, Blood Collection Needle, Spinal Anesthesia and Epidural Needle, Prefilled Syringe Needle, A.V. Fistula Needle, Cannula Needle, and Retractable Syringes), by Application (Sample Collection, Drug Delivery), by End User( Hospitals, Physician Offices, Nursing Home, Dental Laboratories, Diagnostic Centers, Ambulatory Surgical Centers, Homecare Settings, and Others)’

To know the latest trends and insights prevalent in the U.S. Safety Needles Market, click the link below:

https://www.coherentmarketinsights.com/market-insight/us-safety-needles-market-4403

The increasing launches of safety needle used for drug delivery is expected to drive the growth of the U.S. safety needles market. For instance, in September 2019, Owen Mumford, a company manufactures an innovative range of medical device,  launched Ateria SafeControl, the next generation safety pen needles used for administering medicines to patients with diabetes. This product is specially designed to protect healthcare professionals from needlestick injuries (NSIs) while enabling them to keep control of the overall injection process.

Key Takeaways of the U.S. Safety Needles Market:

  • The U.S. safety needles market is expected to exhibit a CAGR of 4.8% over the forecast period, owing to the increasing prevalence of gynecologic cancer and spine disorders is expected to boost the growth of the U.S. safety needles market over the forecast period. For instance, according to Foundation for Women’s Cancer, around 5,170 new cases of vaginal cancer are diagnosed each year in the U.S.
  • Among Product type, the blood collection needles segment is expected to hold a dominant position in the U.S. safety needles market in 2020, owing to increasing need of blood plasma and blood for treatment of patients in the U.S. According to the American National Red Cross, around 7,000 units of platelets and 10,000 units of plasma are required daily in the U.S. and around 21 million blood components are transfused each year in the U.S.
  • Among application, the drug delivery segment is expected to hold a dominant position in the U.S. safety needles market in 2020, owing to increasing launches of safety needle used for drug delivery. For instance, in 2018, ARKRAY USA Inc, a company focusing manufacturing of cost effective medical devices, launched Assure ID Safety Pen Needles used for injection of insulin in diabetic patients
  • Among End user, the hospital segment is expected to hold a dominant position in the U.S. safety needles market in 2020, owing to the increasing number of patient population suffering from traumatic injuries and other chronic condition rising hospital visit of patients suffering from chronic conditions to undergo surgeries. For instance, according to the 2019 report published by the American Society of Plastic Surgeons, in the U.S., around 3,592,576 reconstructive procedures and 4,553,896 cosmetic procedures were performed in hospitals, in 2019
  • Key players operating in the U.S. Safety Needles market include Medtronic Plc., Becton, Dickinson and Company, Boston Scientific Corporation, Smith Medical, Abbott Laboratories, Argon Medical Devices, Inc., Novo Nordisk A/S, Terumo Corporation, Eli Lilly and Company, Nipro Corporation, B.Braun Melsungen AG, Revolutions Medical Corporation, Retractable Technologies, Inc., SOL-MILLENNUM, UltiMed, Inc., Axel Bio Corporation, Inc., Cardinal Health, Inc., Vygon S.A. and Gerresheimer AG
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner